Cutaneous Leishmaniasis
- 1 November 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 125 (11) , 1540-1542
- https://doi.org/10.1001/archderm.1989.01670230082014
Abstract
• The chemotherapy of leishmaniasis is still far from satisfactory. Itraconazole, one of the most recent azole antifungal agents, appears to be well tolerated in man. Two patients with cutaneous leishmaniasis (Leishmania tropica), contracted in Saudi Arabia, were treated orally for 2 months with itraconazole (100 mg/d). Both recovered without side effects or abnormalities in their main biologic parameters. (Arch Dermatol. 1989;125:1540-1542)Keywords
This publication has 11 references indexed in Scilit:
- A Clinical Trial of Itraconazole in the Treatment of Deep Mycoses and LeishmaniasisClinical Infectious Diseases, 1987
- Topical Treatment of Cutaneous LeishmaniasisJournal of Investigative Dermatology, 1986
- Cryosurgery in cutaneous leishmaniasisBritish Journal of Dermatology, 1982
- Oral Ketoconazole in the Treatment of LeishmaniasisInternational Journal of Dermatology, 1982
- Rifampicin Treatment of Cutaneous LeishmaniasisInternational Journal of Dermatology, 1982
- POTENTIATING ACTION OF RIFAMPICIN AND ISONIAZID AGAINST LEISHMANIA MEXICANA AMAZONENSISThe Lancet, 1981
- Treatment of Cutaneous Leishmaniasis with Trimethoprim-Sulfamethoxazole CombinationDermatology, 1973
- THE TREATMENT OF LEISHMANIASIS RECIDIVANS WITH LOCAL INJECTIONS OF AMPHOTERICIN BInternational Journal of Dermatology, 1967
- Plastic surgery in the treatment of cutaneous leishmaniasisBritish Journal of Plastic Surgery, 1962
- TREATMENT OF CUTANEOUS LEISHMANIASIS (ORIENTAL SORE) BY GRENZ RAYSArchives of Dermatology, 1942